BioCatalyst

XENE — Xenon Pharmaceuticals Inc. catalysts

2 verified catalyst event(s) for Xenon Pharmaceuticals Inc. (ticker XENE). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-01 — A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08 (month)
in 1mo
ESTIMATED
 READOUT
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Phase 3 · Major Depressive Disorder
 XENE Xenon Pharmaceuticals Inc. Azetukalner ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-10 (month)
in 3mo
ESTIMATED
 READOUT
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Phase 3 · Focal Onset Seizures
 XENE Xenon Pharmaceuticals Inc. XEN1101 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.